Withheld: gross profit could not be reconciled with the rest of this filer’s statement.
ACACIA RESEARCH CORP (ACTG) reported revenue of $285.23M and net income of $21.68M for the fiscal year ended 2025-12-31. This page shows 9 annual periods of income statement, balance sheet and cash flow figures normalized from ACACIA RESEARCH CORP’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Patent Owners & Lessors.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $285.23M | $122.31M | $125.10M | $59.22M | $88.05M | $29.78M | $11.25M | $131.51M | $65.40M |
| Cost of revenue | $200.75M | $92.66M | $52.83M | $37.39M | $36.10M | $24.82M | $18.29M | $109.26M | Unavailable |
| Gross profit | $84.48M | $29.65M | $72.27M | $21.84M | $51.95M | Unavailable | -$7.04M | $22.25M | Unavailable |
| Operating income | $6.41M | -$32.93M | $20.94M | -$40.09M | $14.54M | -$19.52M | -$23.42M | -$24.69M | -$27.27M |
| Net income | $21.68M | -$36.06M | $67.06M | -$125.06M | $149.20M | $109.23M | -$17.12M | -$105.03M | $22.18M |
| Research & development | Unavailable | Unavailable | $735.00K | $626.00K | $200.00K | $0 | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 97.16M | shares 99.21M | shares 92.41M | shares 42.46M | shares 98.47M | shares 57.44M | shares 50.90M | shares 49.97M | shares 50.69M |
| Pretax income | $31.31M | -$38.15M | $67.43M | -$127.15M | $174.65M | $108.07M | -$18.95M | -$103.67M | $24.64M |
| Income tax expense | $6.84M | -$3.45M | -$1.50M | -$16.21M | $24.29M | -$1.16M | -$1.82M | $1.18M | $2.96M |
| Diluted EPS | $0.22 | $-0.36 | $0.58 | $-3.13 | $1.91 | $1.48 | $-0.40 | $-2.10 | Unavailable |
| Selling, general & administrative | $78.07M | $62.58M | $51.34M | $61.30M | $37.20M | $24.48M | Unavailable | Unavailable | Unavailable |
| General & administrative | $65.12M | $55.36M | $44.43M | $52.68M | $35.67M | $24.48M | $16.38M | $18.73M | $27.22M |
| Selling & marketing | $12.95M | $7.22M | $6.91M | $8.62M | $1.54M | $0 | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $306.72M | $273.88M | $340.09M | $287.79M | $308.94M | $165.55M | $57.36M | $128.81M | $136.60M |
| Total assets | $770.96M | $756.39M | $633.54M | $482.93M | $798.86M | $511.31M | $218.16M | $223.95M | $308.77M |
| Current assets | $450.09M | $420.15M | $554.51M | $427.98M | $730.68M | $457.67M | $173.26M | $201.47M | $139.70M |
| Total liabilities | $186.92M | $203.78M | $43.94M | $193.68M | $353.63M | $212.07M | $35.11M | $32.71M | $13.11M |
| Current liabilities | $49.04M | $49.64M | $27.64M | $87.21M | $200.19M | $124.82M | $11.72M | $31.04M | $9.56M |
| Total equity incl. NCI | $584.03M | $552.62M | $589.61M | $269.32M | $430.48M | $288.32M | $174.96M | $191.24M | $295.66M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $26.56M | $27.48M | $10.92M | $14.22M | $8.93M | $0 | Unavailable | Unavailable | Unavailable |
| Accounts receivable | $26.16M | $26.90M | $80.60M | $8.23M | $9.52M | $506.00K | $511.00K | $32.88M | $153.00K |
| Goodwill | $25.79M | $29.34M | $8.99M | $7.54M | $7.47M | $0 | Unavailable | Unavailable | Unavailable |
| Long-term debt | $91.90M | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts payable | $13.36M | $12.07M | $3.26M | $6.04M | $5.44M | $1.02M | $1.76M | $3.70M | Unavailable |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $75.24M | $50.12M | -$22.51M | -$37.34M | $13.33M | -$19.62M | -$2.31M | $20.88M | $12.97M |
| Capital expenditures | Unavailable | $148.67M | $189.00K | $732.00K | $91.00K | $199.00K | $183.00K | $34.00K | $2.00K |
| Investing cash flow | -$21.01M | -$212.96M | $16.18M | $184.46M | $35.75M | $18.60M | -$68.06M | -$24.07M | -$16.11M |
| Financing cash flow | -$22.73M | $97.56M | $58.63M | -$166.14M | $59.74M | $109.21M | $33.92M | -$4.61M | $700.00K |
| Net change in cash | $32.84M | -$66.21M | $52.30M | -$21.58M | $108.82M | Unavailable | Unavailable | -$7.80M | -$2.45M |
| Stock-based compensation | $5.74M | $4.80M | $3.30M | $3.82M | $2.05M | $1.66M | $1.08M | -$317.00K | $8.88M |
| Common dividends paid | Unavailable | $0 | $1.40M | $2.80M | $1.45M | $1.38M | $0 | Unavailable | $0 |
| Common share repurchases | $0 | $20.29M | $0 | $50.99M | $4.01M | $4.00M | $0 | $4.63M | $0 |
| Depreciation & amortization | $43.35M | $33.57M | $14.73M | $13.51M | $10.69M | $4.80M | $3.23M | $27.14M | $22.24M |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | -$22.70M | -$38.07M | $13.24M | -$19.82M | -$2.49M | $20.84M | $12.96M |
| Gross margin | 29.6% | 24.2% | 57.8% | 36.9% | 59.0% | Unavailable | -62.6% | 16.9% | Unavailable |
| Operating margin | 2.2% | -26.9% | 16.7% | -67.7% | 16.5% | -65.5% | -208.2% | -18.8% | -41.7% |
| FCF margin | Unavailable | Unavailable | -18.1% | -64.3% | 15.0% | -66.5% | -22.2% | 15.8% | 19.8% |
| SBC / revenue | 2.0% | 3.9% | 2.6% | 6.5% | 2.3% | 5.6% | 9.6% | -0.2% | 13.6% |
| Current ratio | 9.18x | 8.46x | 20.06x | 4.91x | 3.65x | 3.67x | 14.79x | 6.49x | 14.62x |
| Revenue YoY growth | 133.2% | -2.2% | 111.2% | -32.7% | 195.6% | 164.8% | -91.4% | 101.1% | Unavailable |
| Net margin | 7.6% | -29.5% | 53.6% | -211.2% | 169.5% | 366.8% | -152.2% | -79.9% | 33.9% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | 1.1% | 0.2% | 0.0% | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | Unavailable | Unavailable | 0.2% | 1.2% | 0.1% | 0.7% | 1.6% | 0.0% | 0.0% |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 21.8% | Unavailable | -2.2% | Unavailable | 13.9% | -1.1% | Unavailable | Unavailable | 12.0% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ACTG in the interactive workspace to inspect any figure back to its filing.
Source filings
Reconciliation checks needing review
5 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
Difference 19924000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
Difference 14753000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
Difference 10924000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
Difference 8089000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.